136 related articles for article (PubMed ID: 27815039)
1. Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.
Gujral DM; Long M; Roe JW; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):42-50. PubMed ID: 27815039
[TBL] [Abstract][Full Text] [Related]
2. Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.
Rosenthal DI; Fuller CD; Barker JL; Mason B; Garcia JA; Lewin JS; Holsinger FC; Stasney CR; Frank SJ; Schwartz DL; Morrison WH; Garden AS; Ang KK
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):455-61. PubMed ID: 19679406
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison between carotid-sparing IMRT and 3DCRT in early glottic cancer patients treated with definitive radiation therapy.
Kaur H; Thakur N; Sharma R; Sudan M; Jain N; Kaur S; Lehal P
J Cancer Res Ther; 2024 Jan; 20(1):327-332. PubMed ID: 38554342
[TBL] [Abstract][Full Text] [Related]
4. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.
Riegel AC; Antone J; Schwartz DL
Med Dosim; 2013; 38(1):66-9. PubMed ID: 22901745
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
6. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer.
Atalar B; Gungor G; Caglar H; Aydin G; Yapici B; Ozyar E
Tumori; 2012; 98(3):331-6. PubMed ID: 22825509
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Simulation Study of Carotid Artery and Pharyngeal Constrictor Muscle Sparing-Radiotherapy in Glottic Carcinoma.
Ozdemir Y; Acibuci I; Selek U; Topkan E
Technol Cancer Res Treat; 2020; 19():1533033820956989. PubMed ID: 33034277
[TBL] [Abstract][Full Text] [Related]
8. Can carotid-sparing radiotherapy approaches replace with conventional techniques for the patients with T1 glottic larynx cancer?
Sert F; Karakoyun-Çelik O; Esassolak MA
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):267-74. PubMed ID: 22991987
[TBL] [Abstract][Full Text] [Related]
9. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
10. Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord.
Chera BS; Amdur RJ; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1380-5. PubMed ID: 19942356
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
12. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
[TBL] [Abstract][Full Text] [Related]
13. Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer.
Hong CS; Oh D; Ju SG; Ahn YC; Noh JM; Chung K; Kim JS; Suh TS
Cancer Res Treat; 2016 Jan; 48(1):63-70. PubMed ID: 25761477
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric and radiobiologic comparison of 3D conformal, IMRT, VMAT and proton therapy for the treatment of early-stage glottic cancer.
Matthiesen C; Herman Tde L; Singh H; Mascia A; Confer M; Simpson H; Higby C; Arain A; Keole S; Herman T; Bogardus C; Zhao YD; Ahmad S
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):221-8. PubMed ID: 25146003
[TBL] [Abstract][Full Text] [Related]
15. Carotid sparing hypofractionated tomotherapy in early glottic cancers: Refining image guided IMRT to improve morbidity.
Chatterjee S; Guha S; Prasath S; Mallick I; Achari R
J Cancer Res Ther; 2013; 9(3):452-5. PubMed ID: 24125982
[TBL] [Abstract][Full Text] [Related]
16. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007.
Bicakci BC; Mustafayev TZ; Cetinayak O; Igdem S; Birgi SD; Meydan D; Demircioglu F; Atalar B; Ozyar E; Akman F
Head Neck; 2022 Aug; 44(8):1825-1832. PubMed ID: 35596585
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
19. An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer.
Gomez D; Cahlon O; Mechalakos J; Lee N
Radiat Oncol; 2010 Aug; 5():74. PubMed ID: 20796303
[TBL] [Abstract][Full Text] [Related]
20. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
